Abstract: A high refractive index composition comprising a core resin mixture comprising a first compound of formula (I), a second compound of a poly(ethylene glycol) di(meth)acrylate of formula (II) and a reactive diluent to provide enhanced impact resistance and refractive index.
Abstract: This invention, in one aspect, relates to processes for electropolishing aluminum, in particular, aluminum alloy metal surfaces, by immersing the metal surface in a polishing solution and making the aluminum alloy material anodic. The polishing solution can comprise a phosphoric acid solution and a hypophosphite-containing compound. The polishing solution can also comprise a polyol, a polyol ether and an organic acid.
Abstract: Embodiments of the present invention described and shown in the specification and drawings include a respiratory system for automatically and variably controlling the supply of a pressurized breathing gas to a patient via a breathing circuit that is in fluid communication with the lungs of the patient. The respiratory system has a demand valve in fluid communication with a source of pressurized gas. The demand valve is switchable between a open position, in which an inhalation conduit of the breathing circuit is in fluid communication with the source of pressurized gas, and a closed position, in which the inhalation conduit is not in fluid communication with the source of pressurized gas. The demand valve is proportionally moveable between the open and closed positions in response to a pressure within a reference chamber which is in fluid communication with the trachea of the patient.
Type:
Grant
Filed:
February 8, 2001
Date of Patent:
June 3, 2003
Assignee:
University of Florida
Inventors:
Michael J. Banner, Paul Bradford Blanch
Abstract: The present invention provides a fusion polypeptide comprising a chemokine and either a tumor or viral antigen which is administered as either a protein or nucleic acid vaccine to elicit an immune response effective in treating cancer or effective in treating or preventing HIV infection.
Type:
Grant
Filed:
September 12, 2000
Date of Patent:
May 13, 2003
Assignee:
The United States of America as represented by the Department
of Health and Human Services
Abstract: A process for coinjection-molding a multilayer article comprising coinjecting at a selected coinjecting temperature (i) a first outer polymer resin layer having a viscosity at the selected coinjecting temperature, and (ii) a second inner polymer resin layer having a viscosity at the selected coinjecting temperature, wherein the ratio of the outer polymer resin viscosity to the inner polymer resin viscosity at the coinjecting temperature is less than or equal to about 2 and the coinjecting temperature is above the melting temperature of the highest melting resin and below the degradation temperature of the lowest degrading resin to form a multilayer article. Processes for coextrusion are also provided.
Type:
Grant
Filed:
March 1, 2000
Date of Patent:
May 13, 2003
Assignee:
Eastman Chemical Company
Inventors:
Marcus David Shelby, Lavonna Suzanne Buehrig, Benjamin Bradford Gamble
Abstract: The present invention provides a composition for targeted delivery of a nucleic acid to a cell comprising a biotinylated recombinant adenovirus, wherein biotin is covalently linked to the recombinant adenovirus, wherein the recombinant adenovirus comprises the nucleic acid, and wherein the recombinant adenovirus is linked via streptavidin to a biotinylated targeting moiety. Also provided by this invention is a method for targeted delivery of a nucleic acid to a selected cell in a subject comprising administering to the subject a composition comprising a biotinylated recombinant adenovirus, wherein biotin is covalently linked to the recombinant adenovirus, wherein the recombinant adenovirus comprises the nucleic acid, and wherein the recombinant virus is linked via streptavidin to a biotinylated targeting moiety that specifically targets the selected cell.
Type:
Grant
Filed:
June 15, 2000
Date of Patent:
April 29, 2003
Assignee:
The United States of America as represented by the Department
of Health and Human Services
Inventors:
Sally E. Spence, Jeffrey S. Smith, Jonathan R. Keller